The BL1/M tumors did not differ significantly from other subtypes with respect to expression of SRC, FYN and LYN , but showed a trend towards lower expression of FGR and the remaining members of the SRC-B sub-family (Fig. 5b ).
← all excerpts
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.
1
—
—